Mangrove Partners’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

Mangrove Partners’s Portfolio ICUCW Stock Details ICUCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-486,737	Closed	-$5M	–	350
2022 Q3	$5M	Sell	486,737 -13,263	-3%	-$1.09K	0.29%	102
2022 Q2	$5.08M	Hold	500,000	–	–	0.25%	94
2022 Q1	$5.06M	Hold	500,000	–	–	0.27%	68
2021 Q4	$5.02M	Hold	500,000	–	–	0.3%	65
2021 Q3	$5.02M	Hold	500,000	–	–	0.45%	46
2021 Q2	$250K	Hold	500,000	–	–	0.03%	290
2021 Q1	$195K	Buy	+500,000	New	+$203K	0.02%	272

Other funds holding ICUCW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Mangrove Partners's ICUCW Position: Q4 2022 in Review

Mangrove Partners sold out of SeaStar Medical Holding Corp Warrant (ICUCW) in Q4 2022, closing a stake of 486,737 shares — an estimated $5M sold.

Mangrove Partners first reported a position in ICUCW in Q1 2021 and held it in 7 quarters. The position peaked at $5.08M in Q2 2022. 31 funds tracked by Wall St. Rank hold ICUCW as of Q4 2022.

Mangrove Partners reported no remaining SeaStar Medical Holding Corp Warrant position as of Q4 2022 after selling out during the quarter.
Mangrove Partners sold 486,737 SeaStar Medical Holding Corp Warrant shares in Q4 2022, an estimated $5M.
Mangrove Partners first reported a position in SeaStar Medical Holding Corp Warrant in Q1 2021 and held it in 7 quarters.
Mangrove Partners's SeaStar Medical Holding Corp Warrant position peaked at $5.08M in Q2 2022.
31 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q4 2022.

Based on Mangrove Partners's 13F filing for Q4 2022, filed 14 Feb 2023.